Macquarie Group
ALIM

Macquarie Group’s Alimera Sciences ALIM Stock Holding History

Macquarie Group’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-523
Closed -$2 – 2191
2024
Q1 		$2 Buy
+523
New +$1.99K ﹤0.01% 1861

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Macquarie Group's ALIM Position: Q2 2024 in Review

Macquarie Group sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 523 shares — an estimated $2 sold.

Macquarie Group first reported a position in ALIM in Q1 2024 and held it in 1 quarter. The position peaked at $2 in Q1 2024. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Macquarie Group reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 523 Alimera Sciences shares in Q2 2024, an estimated $2.
  • Macquarie Group first reported a position in Alimera Sciences in Q1 2024 and held it in 1 quarter.
  • Macquarie Group's Alimera Sciences position peaked at $2 in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.